Rarity Bioscience superRCA technology assays
As part of a co-exclusive distribution agreement, Beckman Coulter Life Sciences will market and distribute Rarity Bioscience’s superRCA technology assays. The assays are claimed to accelerate the detection of mutations by using flow cytometry with logarithmically higher sensitivity compared to the current gold standard digital PCR (dPCR) method.
While traditional flow cytometry research analyses phenotypes, the platform combines a molecular assay based on rolling circle amplification and padlock probes with a flow cytometry readout for high sensitivity and specific multiplex detection of sequence variants, including single point DNA mutations. The assay offers high throughput, resulting in fast turnaround without the need for additional hardware, lowering the barriers to molecular research assays.
Phone: 1800 060 878
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
Immundiagnostik ID-Vit MTP assays
Immundiagnostik's ID-Vit MTP assays range enables the quantification of all eight...
Bertin Bioreagent obesity research ELISA kits
Bertin Bioreagent's obesity research ELISA kits include targets for 20-hydroxyecdysone,...
